Genmab | GEN - Liquidités

Prix De L'Action
1,703.50
Variation Quotidienne
-7.50 -0.44%
Mensuellement
0.89%
Annuel
26.19%
Q2 Prévisions
1,628.53




Liquidités Changement Date
Agios Pharmaceuticals USD 89.13M 3.58M 2025-12
Almirall EUR 337.77M 14.83M 2025-12
Amarin USD 122.8M 25.08M 2025-09
Amgen USD 9.13B 316M 2025-12
argenx SE USD 4.3B 2.21B 2025-09
AstraZeneca USD 8.14B 1.08B 2025-09
Bayer EUR 5.9B 1.34B 2025-09
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Demant DKK 1.33B 188M 2025-12
Exelixis USD 482.49M 106.19M 2025-12
Fresenius Medical Care EUR 1.58B 326.57M 2025-12
Galapagos EUR 87.87M 23.41M 2025-12
Genmab DKK 1.72B 46M 2025-12
GlaxoSmithKline GBP 3.3B 303M 2025-09
GN Store Nord DKK 767M 363M 2025-09
GRIFOLS EUR 558.69M 194.13M 2025-06
Hikma Pharmaceutical USD 236M 48M 2025-06
Insmed USD 510.44M 175.68M 2025-12
Lonza CHF 719M 188M 2025-12
Merck EUR 2.25B 1.08B 2025-09
Novartis USD 9.56B 2.9B 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
UCB EUR 1.57B 1.14B 2024-12